These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27113175)

  • 21. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
    Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
    Gao J; Cao R; Mu H
    Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene Expression of the Circulating Long Noncoding RNA
    Ismail DM; Shaker OG; Kandeil MA; Hussein RM
    Genet Test Mol Biomarkers; 2019 Sep; 23(9):671-680. PubMed ID: 31433231
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
    Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
    Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer.
    Sørensen KP; Thomassen M; Tan Q; Bak M; Cold S; Burton M; Larsen MJ; Kruse TA
    Breast Cancer Res Treat; 2013 Dec; 142(3):529-36. PubMed ID: 24258260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers.
    Gökmen-Polar Y; Vladislav IT; Neelamraju Y; Janga SC; Badve S
    Sci Rep; 2015 Mar; 5():8765. PubMed ID: 25739705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma.
    Wang J; Zhou Y; Lu J; Sun Y; Xiao H; Liu M; Tian L
    Med Oncol; 2014 Sep; 31(9):148. PubMed ID: 25099764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
    Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
    Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
    Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
    Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer.
    Zidan HE; Karam RA; El-Seifi OS; Abd Elrahman TM
    Cancer Genet; 2018 Jan; 220():32-37. PubMed ID: 29310836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
    Tantai J; Hu D; Yang Y; Geng J
    Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer.
    Chen S; Li T; Zhao Q; Xiao B; Guo J
    Clin Chim Acta; 2017 Mar; 466():167-171. PubMed ID: 28130019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
    Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
    Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical value of CEA for detection of distant metastases in newly diagnosed breast cancer: comparison with CA 15-3.
    Maccio G; Goussot V; Berriolo-Riedinger A; Riedinger JM
    Ann Biol Clin (Paris); 2017 Aug; 75(4):431-441. PubMed ID: 28751288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
    Li W; Li N; Kang X; Shi K
    Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: a Chinese population-based study.
    Xu N; Chen F; Wang F; Lu X; Wang X; Lv M; Lu C
    Tumour Biol; 2015 Sep; 36(10):7659-65. PubMed ID: 25929808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma long non-coding RNAs (lncRNAs) serve as potential biomarkers for predicting breast cancer.
    Jiao ZY; Tian Q; Li N; Wang HB; Li KZ
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1994-1999. PubMed ID: 29687854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers.
    Ruan X; Cai G; Wei Y; Gu M; Zhang Y; Zhao Y; Mueck AO
    Menopause; 2020 Feb; 27(2):183-193. PubMed ID: 31876619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA HOTAIR is associated with human cervical cancer progression.
    Kim HJ; Lee DW; Yim GW; Nam EJ; Kim S; Kim SW; Kim YT
    Int J Oncol; 2015 Feb; 46(2):521-30. PubMed ID: 25405331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.